Fulcrum Therapeutics (FULC) Other Non-Current Assets (2018 - 2026)

Fulcrum Therapeutics (FULC) has reported Other Non-Current Assets for 9 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Other Non-Current Assets fell 9.38% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $1.1 million (down 9.38% YoY), while the FY2025 annual figure was $1.2 million, changed 0.0% from the prior year.
• Other Non-Current Assets eased to $1.1 million in Q2 2026 per FULC's latest filing, from $1.2 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.1 million in Q4 2022 and bottomed at $1.1 million in Q1 2022.
• Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $1.2 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 92.77% — and 2024, when it sank 40.28%.
• Fulcrum Therapeutics' Other Non-Current Assets stood at $2.1 million in 2022, then dropped by 4.47% to $2.0 million in 2023, then tumbled by 40.28% to $1.2 million in 2024, then changed by 0.0% to $1.2 million in 2025, then fell by 9.08% to $1.1 million in 2026.
• Business Quant data shows FULC's Other Non-Current Assets at $1.1 million in Q2 2026, $1.2 million in Q1 2026, and $1.2 million in Q4 2025.